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Coronaviruses are a family of positive-stranded RNA viruses
that includes important pathogens of humans and other
animals. The large coronavirus genome (26–31 kb) encodes
15–16 nonstructural proteins (nsps) that are derived from two
replicase polyproteins by autoproteolytic processing. The nsps
assemble into the viral replication–transcription complex and
nsp3, nsp4 and nsp6 are believed to anchor this enzyme
complex to modiﬁed intracellular membranes. The largest part
of the coronavirus nsp4 subunit is hydrophobic and is
predicted to be embedded in the membranes. In this report,
a conserved C-terminal domain ( 100 amino-acid residues)
has been delineated that is predicted to face the cytoplasm and
has been isolated as a soluble domain using library-based
construct screening. A prototypical crystal structure at 2.8 A ˚
resolution was obtained using nsp4 from feline coronavirus.
Unmodiﬁed and SeMet-substituted proteins were crystallized
under similar conditions, resulting in tetragonal crystals that
belonged to space group P43. The phase problem was initially
solved by single isomorphous replacement with anomalous
scattering (SIRAS), followed by molecular replacement using
a SIRAS-derived composite model. The structure consists of
a single domain with a predominantly  -helical content
displaying a unique fold that could be engaged in protein–
protein interactions.
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1. Introduction
The Coronaviridae family, which is comprised of the genera
Coronavirus and Torovirus, and the more distantly related
Arteriviridae and Roniviridae families together form the order
Nidovirales (Gorbalenya et al., 2006). Coronaviruses are
positive-stranded RNA viruses that are frequently associated
with enteric or respiratory diseases in humans, livestock and
companion animals (Dye & Siddell, 2005). At present, they
are formally classiﬁed into three genetic groups (1–3), with the
ﬁrst two groups further divided into two subgroups (1a/b and
2a/b; Gorbalenya et al., 2004; Lai & Holmes, 2001), but as our
understanding of natural coronavirus diversity progresses
novel subgroups continue to be recognized (Woo et al., 2009).
Viruses that belong to different subgroups have diverged
profoundly. A fraction of their proteins are subgroup-speciﬁc
and the amino-acid sequences of their most conserved
proteins may differ by as much as 50%. The best-known
member of this family, severe acute respiratory syndrome
coronavirus (SARS-CoV), belongs to subgroup 2b, whereas
feline coronavirus (FCoV), characterized in this study, belongs
to subgroup 1a (Gorbalenya et al., 2004).Feline infectious peritonitis virus (FIPV) is a pathogenic
FCoV variant that emerged by mutation of the relatively
benign enteric FCoV (Poland et al., 1996; Vennema et al.,
1998) and causes a fatal immune-mediated disease in cats
(Pedersen, 1995). Since the variations are minor and despite
the fact that we are working with a construct derived from an
FIPV strain, we will henceforth use FCoVas an abbreviation
for the virus. The FCoV genome (strain FIPV WSU-79/1146)
consists of 29 125 nucleotides and contains six open reading
frames (ORFs; Dye & Siddell, 2005). The ﬁrst two ORFs,
namely ORF1a and ORF1b, comprising the 50-most gene (i.e.
gene 1), encode two large replicase polyproteins, pp1a and
pp1ab. Proteolytic cleavage of these polyproteins by virus-
encoded proteinases, i.e. the 3C-like main proteinase (M
pro in
nsp5) and the papain-like accessory proteinases (PL
pro 1 and 2
in nsp3), are predicted to give rise to a total of 16 mature
nonstructural proteins (nsps; Ziebuhr et al., 2000; Dye &
Siddell, 2005). In addition to the proteases mentioned above,
associated enzymatic activities have been identiﬁed for several
coronavirus nsps, including deubiquitinating and adenosine
diphosphate-ribose-10-phosphatase (ADRP) functions (nsp3),
RNA-dependent RNA polymerases with low (nsp8) and high
(nsp12) processivity, helicase (nsp13), RNA exonuclease and
N7-methyltransferase(nsp14),RNAendoribonuclease(nsp15)
and 20-O-methyltransferase (nsp16) (Anand et al., 2003;
Bhardwaj et al., 2004; Chen et al., 2009; Cheng et al., 2005;
Gorbalenya et al., 1989; Harcourt et al., 2004; Imbert et al.,
2008; Ivanov, Hertzig et al., 2004; Ivanov, Thiel et al., 2004;
Ratia et al., 2006; Seybert et al., 2000; Snijder et al., 2003).
Tertiary structures, solved using X-ray or/and NMR analyses,
have been reported for a substantial number of nsps from at
least one coronavirus, typically SARS-CoV (reviewed in
Bartlam et al., 2005; Mesters et al., 2006). These structures
represent a variety of separate domains, entire proteins and
even multiprotein complexes. Despite these remarkable
advances, many domains, including those residing in nsp4,
remain poorly characterized.
Nsp4 is an approximately 500-amino-acid replicase subunit
that is released by the combined activity of the nsp3 and nsp5
proteases. It is predicted to be one of the three membrane-
spanning proteins (the others are nsp3 and nsp6) among
coronavirus nsps and bioinformatic analyses consistently
predict four transmembrane domains in nsp4 (Clementz et al.,
2008; Oostra et al., 2007). An N-terminal transmembrane
region (amino acids 1–30) is presumably followed by a large
lumenal domain (amino acids 30–280), three closely spaced
additional transmembrane regions (amino acids 280–400) and
ﬁnally a C-terminal domain of about 100 residues that is
exposed at the cytoplasmic face of the membrane. Corona-
virus infection induces the extensive reorganization of endo-
plasmic reticulum membranes into a reticulovesicular network
(Knoops et al., 2008) that includes many unusual double-
membrane vesicles (Gosert et al., 2002; Harcourt et al., 2004;
Shi et al., 1999; Snijder et al., 2006; Stertz et al., 2007). It is
currently believed that nsp4 functions in anchoring the viral
replication–transcription complex (RTC) to these modiﬁed
membranes and independent genetic studies have demon-
strated its importance for replication (Clementz et al., 2008;
Sparks et al., 2007).
In this paper, we present the ﬁrst X-ray structure of the
C-terminal domain of the FCoV nsp4. Together with structural
data, a family-wide comparative sequence analysis of the nsp4
C-terminal domain was performed in order to identify resi-
dues/regions that might be important for function rather than
for structural integrity.
2. Experimental procedures
2.1. Library-based construct screening
The sequence encoding the FCoV nsp4 (residues 2337–2826
of the polyprotein pp1a from strain FIPV WSU-79/1146;
Genebank/RefSeq accession No. NC_007025.1) was RT-PCR
ampliﬁed from viral RNA and cloned into the pMM8 vector.
pMM8 is a modiﬁed pET-43 (Novagen) bacterial expression
vector containing restriction sites suitable for exonuclease-
based construct-library generation (Cornvik et al., 2006) and a
Gateway cassette for recombination cloning inserted down-
stream of the His-tag coding sequence. An N-terminally
deleted construct library was generated using an exonuclease
strategy and screened for a soluble construct using the colony-
ﬁltration blot (Cornvik et al., 2005, 2006). A soluble and well
expressing construct containing residues 2731–2826 (here
called the nsp4ct domain) was chosen for scale-up expression
and puriﬁcation. This construct has 14 additional N-terminal
residues, including a noncleavable His6 tag.
2.2. Expression
The expression of soluble nsp4ct was performed in
Escherichia coli strain BL21 (DE3) (Novagen). Cultures were
grown at 310 K in LB medium containing 50 mgm l
 1 ampi-
cillin until the OD600 reached 0.8. Protein synthesis was
induced by the addition of 1 mM isopropyl  -d-1-thio-
galactopyranoside (IPTG) and the culture was grown to
stationary phase overnight at 288 K. Cells were harvested by
centrifugation at 4000g (30 min, 277 K) and frozen at 253 K.
Selenomethionine-substituted nsp4ct was expressed in the
non-methionine auxotrophic E. coli strain BL21 (DE3)
(Novagen). Bacteria were grown in minimal medium at 310 K
until the OD600 reached 0.8. Feedback-inhibition amino-acid
mix (Lys, Thr, Phe, Leu, Ile, Val and SeMet) was added and
after 15 min cells were induced with 1 mM IPTG. The culture
was left shaking overnight at 288 K and the cells were subse-
quently harvested by centrifugation at 4000g (30 min, 277 K).
Cell pellets were frozen at 253 K.
2.3. Purification
Both the native and the SeMet-substituted nsp4ct proteins
were puriﬁed following the same protocol. A pellet from 1 l
cell culture was resuspended in 20 ml buffer A (10 mM CHES
pH 9.1 and 300 mM NaCl, plus 2 mM  -mercaptoethanol in
the case of SeMet-substituted nsp4ct). The cells were soni-
cated and the protein was puriﬁed from the soluble cellular
fraction by Ni–NTA afﬁnity chromatography and eluted with
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exchanged into buffer A using PD10 columns (GE Healthcare
Life Sciences). nsp4ct was subsequently concentrated and
applied onto a Superdex 75 (16/60) gel-ﬁltration column (GE
Healthcare Life Sciences) pre-equilibrated with buffer A.T h e
protein was concentrated to 10 mg ml
 1 and its purity was
examined by SDS–PAGE.
2.4. Crystallization
Initial crystallization trials were carried out using the
sitting-drop vapour-diffusion method in 96-well plates
(Greiner) at 292 K at the EMBL Hamburg High-throughput
Crystallization Facility (Mueller-Dieckmann, 2006). Crystals
were obtained under various conditions. Further optimization
of these conditions was performed manually in 24-well plates
(Qiagen) using the hanging-drop vapour-diffusion method at
292 K. Crystals were obtained at a protein concentration of
7m gm l
 1 in 0.22 M ammonium sulfate and 25%(w/v) PEG
5000.
2.5. Data collection and processing
The crystals were cryoprotected in a solution consisting of
0.22 M ammonium sulfate, 25%(w/v) PEG 5000 and 15%(v/v)
ethylene glycol prior to data collection. Three data sets were
collected: two single-wavelength native data sets (data sets 1
and 2) and a single-wavelength anomalous diffraction (SAD)
data set (at peak wavelength; data set 3). Data set 1 was
collected from a single crystal at 100 K on the European
Synchrotron Radiation Facility (ESRF) beamline ID23-2
using a MAR 225 CCD detector. The oscillation range was 1 ,
with a crystal-to-detector distance of 346.2 mm. 90 images
were collected to a maximum resolution of 3.1 A ˚ . Data set 2
was collected from a single crystal at 100 K on the EMBL
beamline X12 at DESY using a MAR 225 detector. The
crystal-to-detector distance was 300 mm, with an oscillation
range of 0.25 . A total of 670 images were collected to a
maximum resolution of 2.76 A ˚ . Data set 3 was also collected
from a single crystal on beamline X12 (EMBL Hamburg). The
crystal-to-detector distance was 280 mm and the oscillation
range was 1 . 200 images at the selenium absorption edge were
collected to a maximum resolution of 3.3 A ˚ .
In all three cases the recorded images were processed with
XDS (Kabsch, 1988) and the reﬂection intensities were
processed with COMBAT and scaled with SCALA (Evans,
1993) from the CCP4 program suite (Collaborative Compu-
tational Project, Number 4, 1994). Data-collection statistics
are shown in Table 1.
2.6. Structure determination
The structure was solved using the SIRAS protocol of the
Auto-Rickshaw automated crystal structure-determination
platform (Panjikar et al., 2005). FA values were calculated
using the program SHELXC (Sheldrick, 2008). Based on an
initial analysis of the data, the maximum resolution for
substructure determination and initial phase calculation was
set to 3.8 A ˚ . 20 selenium positions were found using the
program SHELXD (Sheldrick, 2008). The correct hand of the
substructure was determined using the programs ABS (Hao,
2004) and SHELXE (Sheldrick, 2008). The occupancy of all
substructure atoms was reﬁned using the program BP3 (Pannu
et al., 2003; Pannu & Read, 2004). The initial phases were
improved using density modiﬁcation, noncrystallographic
symmetry (NCS) averaging and phase extension using the
program RESOLVE (Terwilliger, 2000). A partial  -helical
model was produced using the program HELICAP (Morris et
al., 2004). The partial model contained 119 of the total of 440
residues expected for four molecules. The initial phases were
improved by phase combination of experimental and model
phases using the program SIGMAA (Read, 1986). The density
modiﬁcation and fourfold NCS averaging were repeated again
as described above. The resultant phases were used to
continue model building using the program ARP/wARP
(Perrakis et al., 1999), resulting in the placement of 242 resi-
dues. The partial models generated in the intermediate steps
of ARP/wARP were then used to assemble an almost
complete dimer using the graphics program Coot (Emsley &
Cowtan, 2004). This dimer was then used to ﬁnd the second
dimer in the electron density using phased molecular-repla-
cement techniques as implemented in MOLREP (Vagin &
Teplyakov, 1997). 2Fo   Fc and Fo   Fc electron-density maps
calculated at this stage showed additional electron density
indicating the presence of a ﬁfth molecule in the asymmetric
unit. The phased molecular replacement was repeated again to
place the ﬁfth molecule in the electron-density map. The
resultant model was then used for restrained reﬁnement in
REFMAC5 (Murshudov et al., 1997), including use of the
translation, libration and screw method (TLS; Schomaker &
Trueblood, 1968) for describing group motions.
The structure was manually modiﬁed, followed by cycles of
reﬁnement, using the program Coot. The progress of the
reﬁnement was monitored by means of the free R factor
(Bru ¨nger, 1992). Water molecules were included where clear
peaks were present in both the 2Fo   Fc and Fo   Fc maps and
where appropriate hydrogen bonds could be made to
surrounding residues or to other water molecules. The
stereochemistry of the model was evaluated with the program
MOLPROBITY (Davis et al., 2007).
Interfaces between molecules were analyzed with the PISA
server (Krissinel & Henrick, 2007). Interactions between
molecules were initially evaluated using the CCP4 program
CONTACT with a maximum contact distance of 3.6 A ˚ .
3. Results and discussion
3.1. Structure determination
The recombinant His6-tagged FCoV nsp4ct domain (resi-
dues 2731–2826 of pp1a and residues 395–490 of nsp4; here
renumbered as 1–96) was expressed in E. coli. The protein was
also expressed with the substitution of methionine by seleno-
methionine (SeMet). The incorporation of SeMet was veriﬁed
by matrix-assisted laser desorption ionization (MALDI) mass
spectrometry. Both native and SeMet-substituted proteins
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containing ammonium sulfate and PEG
5000. The crystals belonged to space
group P43, with unit-cell parameters
a = b = 127.5, c = 42.8 A ˚ (data set 2 in
Table 1). There are ﬁve molecules
(chains A–E) in the asymmetric unit,
which corresponds to a 64% solvent
content (Matthews, 1968). The structure
was reﬁned at 2.8 A ˚ resolution to a ﬁnal
R value of 24.0% (Rfree = 29.9%). The
ﬁnal model contains 96 residues in
molecule A (residues 0–95), 93 residues
in molecule B (residues 0–49 and 53–
95), 92 residues in molecule C (residues
0–91), 91 residues in molecule D (resi-
dues 1–91) and 84 residues in molecule
E (residues 0–49 and 56–89). 88.0% of
the residues are located in the preferred
regions of the Ramachandran diagram and 10.9% are in
allowed regions. Residues Met55 (chains A and B), Glu57
(chains C and D) and Ala58 (chains A–E) are Ramachandran
outliers. Glu57 and Ala58 are located in the N-terminus of
helix  3. The geometry in this region may be inﬂuenced by
hydrogen bonding between Glu57 O
" and Arg61 N
 .T h e
reﬁned structure contains two sulfate ions and 40 solvent
molecules. A detailed summary of the data-collection and
structure-reﬁnement statistics is given in Tables 1 and 2.
3.2. Overall structure
The FCoV nsp4ct structure contains six short  -strands
 1– 6 and four  -helices  1– 4 (Fig. 1). Strands  1 and  2
and strands  3 and  5 form small two-stranded antiparallel
sheets. Strands  4 and  6 participate in the formation of the
dimer interface. Strand  4 is observed in molecules C and D
and strand  6 is observed in molecules A–D. The character-
istic feature of the structure is the 21-residue-long helix
 4. Analysis using EBI web tools (PDBsum/ProFunc,
Catalytic site search; http://www.ebi.ac.uk), DALI (http://
ekhidna.biocenter.helsinki.ﬁ/dali_server/) and GRATH (http://
protein.hbu.cn/cath/cathwww.biochem.ucl.ac.uk/cgi-bin/cath/
Grath.html) for both the monomer and dimer did not result in
any signiﬁcant indicators of function or similarities in struc-
ture. The structure therefore represents a novel protein fold.
Nsp4ct has nine conserved and two nonconserved hydro-
phobic residues (Fig. 2) which form the hydrophobic core of
the structure. These residues are grouped into a mainly
aliphatic group (Phe19, Ile21, Leu29, Ile38, Leu68, Leu72) and
two aromatic groups (Phe11, Tyr41, Tyr65 and Tyr26, Tyr75)
(Fig. 3).
The r.m.s.d. between C
  atoms of molecules A–E is less than
0.1 A ˚ (for the 63 common C
  atoms). Differences between
molecules are present in the N-terminus (residues 0–4), the
C-terminus (from residue 88 onwards) and the region between
residues 46 and 64, which includes the C-terminal part of helix
 3, the ﬂexible loop L 3– 4 and the N-terminus of helix  4.
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Table 2
Reﬁnement.
Space group P43
Resolution range (A ˚ ) 19.9–2.8
No. of reﬂections (working/free) 17247/927
No. of protein residues A, 96; B, 93; C, 92; D, 91; E,8 4
No. of waters 40
No. of sulfate molecules 2
Rwork/Rfree (%) 24.0/29.9
Average B (A ˚ 2) 68.7
R.m.s. deviation from ideal values
Bond lengths (A ˚ ) 0.012
Bond angles ( )1 . 6
Figure 1
Overall structure of nsp4ct domain (molecule A is shown).  -Helices are
shown in purple,  -strands are shown in yellow, loops and termini are
shown in light blue and regions forming  -strands present only in the
dimer interface are depicted in red.
Table 1
Data collection.
Values in parentheses are for the last resolution shell.
Data set 1 (native) 2 (native) 3 (SeMet)
Crystallization conditions 0.22 M (NH4)2SO4,
25%(w/v) PEG 5000
0.22 M (NH4)2SO4,
25%(w/v) PEG 5000
0.22 M (NH4)2SO4,
25%(w/v) PEG 5000
X-ray source ID23-2 X12 X12
Space group P43 P43 P43
Unit-cell parameters (A ˚ ) a = b = 128.0, c = 43.7 a = b = 127.5, c = 42.7 a = b = 128.7, c = 42.3
Wavelength (A ˚ ) 0.872 0.978 0.9777
Resolution range (A ˚ ) 50.0–3.1 20.0–2.8 50.0–3.3
Mosaicity 0.14 0.16 0.2
Mean I/ (I) 14.1 (2.9) 23.2 (3.6) 11.9 (4.0)
Rfac (linear) (%) 8.5 (44.7) 5.3 (44.1) 9.7 (32.9)
Redundancy 3.6 6.8 3.8
Rmeas (%) 10.2 (56.2) 5.7 (48.0) 11.1 (37.8)
No. of observations 48030 109977 76895†
No. of unique reﬂections 13150 18178 20164†
Completeness (%) 99.3 (97.7) 99.1 (96.6) 99.2 (96.1)
† Friedel pairs were not merged.3.3. Dimer interface
The FCoV nsp4ct crystal contains ﬁve molecules in the
asymmetric unit. Molecules A/C and B/D form very similar
dimers (Fig. 4a), each of approximate dimensions 60   20  
20 A ˚ . The average buried surface area per molecule is
approximately 961 A ˚ 2. The buried surface of each dimer
involves approximately 25 residues from  1,  3,  4, loop
L 3– 4 and the C-terminus. Interestingly, the interaction
interface contains an intramolecular three-stranded anti-
parallel  -sheet. The order of the strands in this sheet is  4C-
 6A- 6C in the case of dimer A/C and  4D- 6B- 6D in the case
of dimer B/D. Strands  4C and  4D include residues 51–53,
strands  6A and  6B include residues 89–92 and strands  6C
and  6D include residues 88–90. The major interactions at this
interface are the  -sheet hydrogen bonds Val89 N   Gly53 O,
Val89 O   Gly53 N, Ser90 N   Ser90 O, Ser90 O   Ser90 N,
Val91 N   Tyr51 O, Asn92 N   Tyr88 OandAsn92 O   Tyr88 N.
Five hydrogen bonds located outside the  -sheet region are
formed: Met55 O   Tyr60 O
 ,T yr 6 0O
    Met55 O, Tyr60 O
    
Met55 N, Thr94 O
    Thr85 O and Thr94 O
    Thr85 O
 
(Fig. 4b). Strong van der Waals contacts between residues in
the dimer buried area are also important in deﬁning the
interface.
The results obtained from analytical size-exclusion chro-
matography of nsp4ct demonstrated that the protein is
monomeric in solution under the experimental conditions
used (results not shown). Furthermore, the crystal structure
contains a monomer as well as two dimers. The buried surface
area supports the likelihood of dimerization and this may have
physiological signiﬁcance. It is conceivable that in vivo nsp4
dimerization during membrane modiﬁcation or formation of
the RTC may help in bringing the components together and
could therefore aid their correct spatial orientation. This
would agree with the previously proposed role of nsp4 as an
anchor for the assembly of the viral RTC.
3.4. Nsp4ct sequence alignment
Fig. 2 shows the sequence alignment, produced with
ClustalW2 (Larkin et al., 2007), of the C-terminal domain of
nsp4 for the ﬁve coronaviral subgroups. These viruses are
FCoV (group 1a), human coronavirus NL63 (HCoV-NL63;
group 1b), murine hepatitis virus (MHV; group 2a), SARS-
CoV (group 2b) and infectious bronchitis virus (IBV; group 3).
The nsp4ct sequence identity between viruses belonging to the
same group (but different subgroups) is higher than that for
viruses belonging to different groups. The sequence identity
between FCoV and HCoV-NL63 is 68% and that between
MHVand SARS-CoV is 53%. IBV, on the other hand, is the
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Figure 2
Alignment of amino-acid sequences from nsp4ct proteins, coupled with secondary-structure information from the FCoV nsp4ct three-dimensional
structure. The alignment is based on amino-acid data for feline infectious peritonitis virus (FCoV, NC_007025.1), human coronavirus NL63 (HCoV,
ABE97129), murine hepatitis virus (MHV, NP_001012459.1), severe acute respiratory syndrome coronavirus (SARS_CoV, NP_904322.1) and infectious
bronchitis virus strain Beaudette (IBV, NP_740625). The alignment was produced with ClustalW2 (Larkin et al., 2007) and edited with JalView. Residues
are coloured according to conservation from fully conserved (dark blue) to nonconserved (colourless).
Figure 3
A ribbon view of FCoV nsp4ct is shown with the side chains of the
hydrophobic residues important for protein folding depicted as van der
Waals spheres. The residues are divided into three groups, namely the
mainly aliphatic group (Phe19, Ile21, Leu29, Ile38, Leu68 and Leu72,
yellow), aromatic group 1 (Phe11, Tyr41 and Tyr65, red) and aromatic
group 2 (Tyr26 and Tyr75, green).most distantly related virus and its sequence identity in all
possible combinations with the other viruses is around 35%.
This is consistent with previously published phylogenetic
analyses of coronaviruses (Gorbalenya et al., 2004). The
sequence alignment shows a high level of conservation of the
nsp4ct domain, with 17 of around 100 residues being identical
between all ﬁve subgroups. Most of the aromatic amino acids
of coronavirus nsp4ct are highly conserved. This includes
residues Phe19, Tyr41, Tyr50, Tyr60 and Tyr84, which are fully
conserved, and Phe11 (Tyr in IBV), Tyr26 (Phe in IBV), Phe45
(Tyr in four other coronaviruses) and Tyr51 and Tyr75 (both
Phe in MHV and SARS-CoV). Interestingly, Phe45, Tyr50,
Tyr51, Tyr60 and Tyr84 are part of the FCoV nsp4ct dimer
interface and the fully conserved Tyr60 forms a side-chain
(O
 ) hydrogen-bond interaction with the main-chain carbonyl
of Met55 from the second monomer. The two fully conserved
C-terminal residues (Leu95 and Gln96) are part of the
recognition site for the coronavirus M
pro (Hegyi & Ziebuhr,
2002).
There are four clusters of highly conserved residues. The
ﬁrst is between residues 9 and 19 and includes residues in helix
 1 and strand  3. The second comprises residues 45–53 that
belong to helix  3 and part of loop L 3– 4. Interestingly, the
ﬁve independent chains of the FCoV nsp4ct structure differ
most profoundly in this region, suggesting that it is highly
ﬂexible. In the cases of molecules B and E it was disordered
and there was no electron density visible for residues 50–52
and 50–55, respectively. In molecules A, C and D this region
could be placed into electron density and is involved in dimer
formation. High sequence conservation of this cluster and its
structural ﬂexibility suggests that it may play an important role
in the nsp4ct domain function. Residues 60–71 that belong to
helix  4 form the third highly conserved cluster and the fourth
cluster consists of the C-terminal residues 81–96. This last
cluster contains the highly conserved Tyr84,
Pro86 and Pro87 which form the YxPP
motif, which is the inverse of the consensus
PPxY sequence recognized by the class I
WW domains (Linn et al., 1997). Di Leva et
al. (2006) showed that the class I WW
domain does not require a peptide with a
consensus sequence and can also bind an
inverted peptide sequence. The only condi-
tion is the presence of the polyproline II
(PPII) conformation, which is observed in
the case of FCoV nsp4ct. This suggests that
region 84–87 is a reasonable candidate for
protein–protein interactions. PROSITE
(http://www.expasy.org/prosite/) analysis of
all FCoV nsps did not identify any possible
WW domains, suggesting that the YxPP
motif interacting partner is a host protein.
Furthermore, localization of the Pro–Pro
motif may protect the extended unstruc-
tured C-terminus from proteolytic cleavage
by host enzymes (Vanhoof et al., 1995).
4. Conclusions
The high conservation of the C-terminal
domain of nsp4 suggests not only that it
plays a ubiquitous role in the coronavirus
life cycle, but also that nsp4 proteins from
different subgroups are structurally similar
and have similar modes of operation. In this
context, it is a surprising ﬁnding that dele-
tion of the nsp4ct of MHV (using a reverse
genetics system) was reported to be toler-
ated by the virus (Clementz et al., 2008;
Sparks et al., 2007), with the resulting
mutant displaying a modestly attenuated
phenotype. Thus, although a similar mutant
has not been generated for FCoV or any
other coronavirus, the conservation of the
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Figure 4
(a) The dimer interface between molecules A and C is shown in cartoon representation as a
stereo pair. Molecule A is shown in green and molecule C is shown in yellow. The surfaces of
the monomers at the interface are shown in mesh representation. (b) Hydrogen bonds
at the dimer interface Val89 N   Gly53 O, Val89 O   Gly53 N, Ser90 N   Ser90 O,
Ser90 O   Ser90 N, Val91 N   Tyr51 O, Asn92 N   Tyr88 O, Asn92 O   Tyr88 N,
Met55 O   Tyr60 O
 , Tyr60 O
    Met55 O, Tyr60 O
    Met55 N, Thr94 O
    Thr85 O and
Thr94 O
    Thr85 O
  are shown as dashed lines. Molecule A is shown in green, molecule C is
shown in yellow, O atoms are shown in red and N atoms are shown in blue. For clarity, the
arrows (cartoon representation) of the strands forming the dimer interface are not shown in
this panel.nsp4ct domain outlined above would suggest that it is not
absolutely required for coronavirus RNA synthesis and/or
RTC formation per se. This opens the possibility that, like
some other recently characterized coronavirus enzyme func-
tions (Eriksson et al., 2008; Roth-Cross et al., 2009), the nsp4ct
domain might play a role in speciﬁc virus–host interactions of
the type that are not easily uncovered in cell culture-based
systems for virus propagation. Further functional studies are
required in order to better understand the detailed role of
nsp4 and to identify its partners and therefore its signiﬁcance
in the viral life cycle.
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